Joel Sunshine
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- RNA Interference and Gene Delivery 15
- Advanced biosensing and bioanalysis techniques 12
- Oncology 25
- CAR-T cell therapy research 11
- Cancer Immunotherapy and Biomarkers 8
- Polyomavirus and related diseases 6
- Cutaneous Melanoma Detection and Management 4
- Co-authors
- Jordan J. Green (26 shared papers)Janis M. Taube (8 shared papers)Jonathan P. Schneck (3 shared papers)Karlo Perica (3 shared papers)Randall A. Meyer (4 shared papers)Róbert Langer (2 shared papers)Daniel G. Anderson (2 shared papers)Stephany Y. Tzeng (7 shared papers)
- Journals
- Laboratory Investigation (3 papers)Biomaterials (3 papers)Journal of Cutaneous Pathology (2 papers)American Journal of Dermatopathology (2 papers)Cancer Research (2 papers)
- Partner nations
- United StatesSouth KoreaRussia
In The Last Decade
Joel Sunshine
54 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Immunology 887
- Oncology 1.0k
- Biomaterials 405
- Molecular Biology 1.5k
- Genetics 374
Countries citing papers authored by Joel Sunshine
This map shows the geographic impact of Joel Sunshine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Sunshine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Sunshine more than expected).
Fields of papers citing papers by Joel Sunshine
This network shows the impact of papers produced by Joel Sunshine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Sunshine. The network helps show where Joel Sunshine may publish in the future.
Co-authors
The 25 scholars most cited alongside Joel Sunshine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD-1/PD-L1 inhibitors Hit paper breakdown → | 2015 | 421 |
| 2 | 2009 | 243 | |
| 3 | 2013 | 213 | |
| 4 | 2017 | 189 | |
| 5 | 2015 | 164 | |
| 6 | 2012 | 148 | |
| 7 | 2011 | 139 | |
| 8 | 2016 | 135 | |
| 9 | 2017 | 109 | |
| 10 | 2011 | 106 | |
| 11 | 2015 | 101 | |
| 12 | 2009 | 99 | |
| 13 | 2018 | 87 | |
| 14 | 2012 | 81 | |
| 15 | 2010 | 80 | |
| 16 | 2013 | 78 | |
| 17 | 2013 | 78 | |
| 18 | 2013 | 66 | |
| 19 | 2011 | 52 | |
| 20 | 2011 | 44 |
About Joel Sunshine
Joel Sunshine is a scholar working on Molecular Biology, Oncology, Immunology, Genetics and Biomedical Engineering, having authored 58 papers that have together received 2.9k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (15 papers), Advanced biosensing and bioanalysis techniques (12 papers), CAR-T cell therapy research (11 papers), Immunotherapy and Immune Responses (10 papers), Virus-based gene therapy research (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Polyomavirus and related diseases (6 papers) and Cutaneous Melanoma Detection and Management (4 papers). The work is most often cited by research in Immunology (887 citations), Oncology (1.0k citations), Biomaterials (405 citations), Molecular Biology (1.5k citations) and Genetics (374 citations). Joel Sunshine has collaborated with scholars based in United States, South Korea and Russia. Frequent co-authors include Jordan J. Green, Janis M. Taube, Jonathan P. Schneck, Karlo Perica, Randall A. Meyer, Róbert Langer, Daniel G. Anderson, Stephany Y. Tzeng, Drew M. Pardoll and Kevin T. Love. Their work appears in journals such as Laboratory Investigation, Biomaterials, Journal of Cutaneous Pathology, American Journal of Dermatopathology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.